Skip to Content

Alvotech 

Securities Class Action

  • Date:
  • 11/5/2025
  • Company Name:
  • Alvotech
  • Stock Symbol:
  • ALVO
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO) on behalf of Alvotech stockholders. Our investigation concerns whether Alvotech has violated the federal securities laws and/or engaged in other unlawful business practices.

On November 3, 2025, Alvotech received a Complete Response Letter from the FDA regarding its AVT05 BLA biologics license application following a failed facility inspection in July 2025. On this news, Alvotech’s stock fell $2.62, or 34.25%, to close at $5.03 per share.
 
If you purchased or otherwise acquired Alvotech shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com with any questions regarding the case.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Alvotech. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: